Adam Mecca, MD, PhD
Adam Mecca, M.D., Ph.D. is an Assistant Professor of Psychiatry and the Associate Director of the Yale Alzheimer’s Disease Research Unit. He received his B.S. in Chemistry, Microbiology and Cell Science from the University of Florida in 2005 before matriculating to the UF M.D.-Ph.D. program from which he graduated in 2012. Dr. Mecca completed a residency in Psychiatry and a fellowship in Geriatric Psychiatry at Yale University. He practices at the Yale Adler Geriatric Assessment center and is a faculty member in the Yale Department of Psychiatry. In his role as Associate Director of the Yale Alzheimer’s Disease Research Unit, Dr. Mecca works with a team to conduct clinical research of potential therapies for Alzheimer’s disease. He and is collaborators are developing neuroimaging methods to investigate the neurobiology of Alzheimer’s disease. Their recent efforts have led to a novel positron emission tomography imaging technique to measure decreases in the number of connections between nerve cells in people with Alzheimer’s disease. The goal of this work is to develop a clearer understanding of Alzheimer’s disease and develop treatments.
Financial relationships
**Disclaimer**
This Continuing Medical Education (CME) Learning Management System, Ethos, includes individuals designated as 'faculty' for CME purposes. Please note that the term 'faculty' refers solely to their role as a contributor/planner within a CME activity and does not imply any formal affiliation with UT Southwestern Medical Center (UTSW). The display of names and credentials is intended for educational purposes only and does not necessarily indicate a professional or academic relationship with UTSW. Participants are encouraged to verify the affiliations and credentials of faculty members independently if further clarification is needed.